Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Nystatin 200000 unit oromucosal lozenge |
Is a |
Product containing nystatin in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Skin antifungal agent |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Nystatin (substance) |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has manufactured dose form |
Oromucosal lozenge |
true |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
Product manufactured as oromucosal dose form (product) |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Count of base of active ingredient |
un |
false |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Has unit of presentation |
Lozenge |
true |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Nystatin (substance) |
true |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
This attribute specifies the numerator unit for the presentation strength of a product. |
Unit |
true |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
This attribute specifies the denominator unit for the presentation strength of a product. |
Lozenge |
true |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Has presentation strength numerator value |
200000 |
false |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Nystatin (substance) |
true |
Inferred relationship |
Some |
1 |
|
Nystatin 200000 unit oromucosal lozenge |
Is a |
Product containing only nystatin in oromucosal dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Nystatin 200000 unit oromucosal lozenge |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|